tirzepatide vs tesamorelin – Power Peptides Every GLP-1 receptor agonist on

Wegovy is a weight loss injection that belongs to the GLP-1 receptor agonist family of medications, which means it mimics the GLP-1 hormone

Mechanism of Action Metformin decreases hepatic glucose production and improves hepatic insulin sensitivity but has only a modest impact on peripheral insulin-mediated glucose uptake (i.e., insulin resistance), which is likely due to a reduction in hyperglycemia, triglycerides, and free fatty acid levels (48,49)

It is studied in preclinical endocrinology for its ability to stimulate pulsatile growth hormone release while minimizing activation of the cortisol and prolactin pathways under controlled experimental conditions

Most tirzepatide side effects are mild to moderate in severity